| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 06/20/2001 | CN1300222A Strategically modified hepatitis b core proteins and their derivatives |
| 06/20/2001 | CN1300220A Peptide compositions and formulations and use of same |
| 06/20/2001 | CN1299973A HCV-free-blood external preparing method |
| 06/19/2001 | US6248904 Phthalein dyes |
| 06/19/2001 | US6248865 Compounds useful for the synthesis of dolastatin analogs |
| 06/19/2001 | US6248864 Compounds and methods and modulating tissue permeability |
| 06/19/2001 | US6248713 Cell adhesion inhibitors |
| 06/19/2001 | US6248587 Contacting cells with angiotensin/angiotensinogen derivative of specific amino acid sequence |
| 06/19/2001 | US6248561 UCP3 genes |
| 06/19/2001 | US6248558 Sequence and method for genetic engineering of proteins with cell membrane translocating activity |
| 06/19/2001 | US6248543 Detecting microbiocides in sample; mix modulator and protein in sample and detect binding of modulator and protein |
| 06/19/2001 | US6248304 Piperidine compound |
| 06/19/2001 | CA2218616C Nitrosylated neuropeptides |
| 06/19/2001 | CA1341257C Benzhydrylamine derivatives |
| 06/14/2001 | WO2001042423A2 Compositions and methods for detecting stress-inducible proteins |
| 06/14/2001 | WO2001042282A1 Depsipeptide and congeners thereof for use as immunosuppressants |
| 06/14/2001 | WO2001042281A1 Compositions for treating abnormalities in glomerular filtration, patent ductus arteriosus and osteoporosis |
| 06/14/2001 | WO2001042277A2 Complementary peptide ligands generated from the human genome |
| 06/14/2001 | WO2001042276A1 Complementary peptide ligands generated from higher eukaryote genome sequences |
| 06/14/2001 | WO2001041811A2 Carrier peptide and method for delivery of molecules into cells |
| 06/14/2001 | WO2001041788A1 INDUCING CELLULAR IMMUNE RESPONSES TO p53 USING PEPTIDE AND NUCLEIC ACID COMPOSITIONS |
| 06/14/2001 | WO2001041787A1 INDUCING CELLULAR IMMUNE RESPONSES TO HER2/neu USING PEPTIDE AND NUCLEIC ACID COMPOSITIONS |
| 06/14/2001 | WO2001041534A2 Pseudomycin phosphate prodrugs |
| 06/14/2001 | CA2396739A1 Compositions for treating abnormalities in glomerular filtration, patent ductus arteriosus and osteoporosis |
| 06/14/2001 | CA2396513A1 Pseudomycin phosphate prodrugs |
| 06/14/2001 | CA2393738A1 Inducing cellular immune responses to her2/neu using peptide and nucleic acid compositions |
| 06/14/2001 | CA2393662A1 Inducing cellular immune responses to p53 using peptide and nucleic acid compositions |
| 06/14/2001 | CA2393589A1 Compositions and methods for detecting stress-inducible proteins |
| 06/13/2001 | EP1106998A2 Improved sensor membranes |
| 06/13/2001 | EP1106626A1 Process for the preparation of regular glycopeptides |
| 06/13/2001 | EP1106625A1 Rhesus D specific peptide sequences |
| 06/13/2001 | EP1105505A2 Compound and method for the prevention and/or the treatment of allergy |
| 06/13/2001 | EP1105503A2 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE ALPHA1/BETA1 (hsGCALPHA1/BETA1) |
| 06/13/2001 | EP1105487A1 Recombinant multivalent malarial vaccine against plasmodium falciparum |
| 06/13/2001 | EP1105422A1 Hepatitis c inhibitor peptides |
| 06/13/2001 | EP1105421A2 Anti-inflammatory peptides derived from il-2 and analogues thereof |
| 06/13/2001 | EP1105420A1 Cyclic prosaposin-derived peptides and uses thereof |
| 06/13/2001 | EP1105414A2 Synthetic peptides and methods of use for autoimmune disease therapies |
| 06/13/2001 | EP1105409A2 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| 06/13/2001 | EP1105404A1 Purification of oligomers using dual-end selection |
| 06/13/2001 | EP1105152A1 Tnf-derived peptides for use in treating oedema |
| 06/13/2001 | EP1105149A1 Methods to increase blood flow to ischemic tissue |
| 06/12/2001 | US6245883 An isolated lectin derived peptide; therapy, antiinflammatory agent, suppressing cell adhesion, antimetastasis agents |
| 06/12/2001 | US6245764 β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins |
| 06/12/2001 | US6245738 Cytokine restraining agents |
| 06/12/2001 | US6245736 Use of peptidic bradykinin antagonists for the treatment and prevention of Alzheimer's disease |
| 06/12/2001 | US6245734 Activate apoptosis on human pancreatic adenocarcinoma cells |
| 06/12/2001 | US6245502 Target system |
| 06/12/2001 | US6245342 Mixture of oligopeptide, enzyme and carrier |
| 06/12/2001 | US6245337 Haemophilus adherence and penetration proteins |
| 06/12/2001 | US6245333 Isolated protein processed to peptides which form complexes with HLA molecules |
| 06/12/2001 | CA2203689C Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides |
| 06/12/2001 | CA2171453C Glutathione analogs and paralog panels comprising glutathione mimics |
| 06/12/2001 | CA1341250C Method for inducing biological coverings in wounds |
| 06/07/2001 | WO2001040265A2 Ligands for a target molecule and a method for indentifying them |
| 06/07/2001 | WO2001040262A1 Alpha-ketoamide inhibitors of hepatitis c virus ns3 protease |
| 06/07/2001 | CA2392797A1 Method of identifying a ligand for a target molecule |
| 06/07/2001 | CA2390349A1 Alpha-ketoamide inhibitors of hepatitis c virus ns3 protease |
| 06/06/2001 | EP1104887A2 A method and test kit for assaying collagen fragments in body fluids |
| 06/06/2001 | EP1104883A2 Improved sensor membranes |
| 06/06/2001 | EP1104438A2 Novel anti-diabetic peptides |
| 06/06/2001 | EP1104437A2 Antimicrobial peptides isolated from the skin of american frogs |
| 06/06/2001 | EP1104304A1 Multivalent avb3 and metastasis-associated receptor ligands |
| 06/06/2001 | EP0907312A4 Compositions and methods for taxol biosynthesis |
| 06/06/2001 | CN1298410A A process for the conversion of echinocandin class of peptides to their C4-homotyrosine monodeoxy analogues |
| 06/05/2001 | US6242578 Glycoconjugate of carbohydrate covalently bound to peptide of defined amino acid sequence; prevention of influenza virus binding to cells, treatment of schizophrenia, and diagnosis of chronic viral diseases related to cancer |
| 06/05/2001 | US6242568 Zinc finger protein derivatives and methods therefor |
| 06/05/2001 | US6242565 Method for preparing a peptide derivative, and intermediates for the preparation of the peptide derivative, and method for preparing the intermediates |
| 06/05/2001 | US6242183 Interaction trap systems for detecting protein interactions |
| 06/05/2001 | US6242174 Detecting antibodies generated from viral infection; analyze test samples in preferential mixtures designed to bind viral antigens |
| 06/05/2001 | US6241965 Somatostatin derivatives and their radiolabelled products |
| 05/31/2001 | WO2001038547A2 Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells |
| 05/31/2001 | WO2001038397A1 N-alkylated peptides having antiangiogenic activity |
| 05/31/2001 | WO2001038394A2 Polypetptides and methods for thymic vaccination |
| 05/31/2001 | WO2001038347A2 Peptides having antiangiogenic activity |
| 05/31/2001 | WO2001038346A2 Short peptides to target epithelial cells |
| 05/31/2001 | WO2001037856A1 Urotensin-ii cyclic analogs |
| 05/31/2001 | WO2001037780A2 Urotensin-ii analogs |
| 05/31/2001 | WO2000069472A3 Enzyme-activated anti-tumor prodrug compounds |
| 05/31/2001 | WO1999064041A9 Multibinding agents that modulate nmda receptors |
| 05/31/2001 | CA2392490A1 Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells |
| 05/31/2001 | CA2392387A1 Polypeptides and methods for thymic vaccination |
| 05/31/2001 | CA2391386A1 Peptides having antiangiogenic activity |
| 05/31/2001 | CA2386893A1 N-alkylated peptides having antiangiogenic activity |
| 05/30/2001 | EP1102789A1 Monocyclic compounds having nk-2 antagonist action and compositions containing them |
| 05/30/2001 | EP1102785A1 COMPOSITIONS AND METHODS FOR DRUG DELIVERY USING pH SENSITIVE MOLECULES |
| 05/30/2001 | EP1102784A1 A compound containing a labile disulfide bond |
| 05/30/2001 | EP1102776A1 Water soluble prodrugs of hindered alcohols or phenols |
| 05/30/2001 | EP1102597A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht 4 receptors |
| 05/30/2001 | EP1102596A1 Peptide antagonists of zonulin and methods for use of the same |
| 05/30/2001 | EP0914334B1 Process and intermediates for the synthesis of lhrh antagonists |
| 05/30/2001 | EP0859785B1 Cyclic peptide analogs of somatostatin |
| 05/30/2001 | EP0730607B1 Novel integrin-binding peptides |
| 05/30/2001 | EP0621788B1 Hemoregulatory peptides |
| 05/30/2001 | CN1297664A Method for controlling connections to mobile station |
| 05/29/2001 | US6240336 Control unit for an irrigation system |
| 05/29/2001 | US6239255 Immobilizing molecule to gold surface by attaching gold binding polypeptide-alkaline phosphatase chimera, cleaving off alkaline phosphatase domain, then binding desired molecule to polypeptide by protease resistant linkage |
| 05/29/2001 | US6239110 Synthetic analogs of thrombospondin and therapeutic use thereof |
| 05/29/2001 | US6239109 Method of promoting erythropoiesis |
| 05/29/2001 | US6239107 Treatment of male impotence or treatment of neurodegenerative diseases |